Cash · 2011–2025

Vanda Pharmaceuticals cash

$84.9M−17.1% · FY2025

Vanda Pharmaceuticals (VNDA) reported $84.9M in cash for fiscal 2025, −17.1% year on year.

$87.9M2011$88.8M2012$64.8M2013$60.9M2014$50.8M2015$40.4M2016$33.6M2017$61.0M2018$45.1M2019$61.0M2020$52.1M2021$135M2022$136M2023$102M2024$84.9M2025
Vanda Pharmaceuticals — Cash, 2011–2025
Fiscal yearCashChangeFiling
FY20252025-12-31$84.9M−17.1%Open →
FY20242024-12-31$102M−24.7%Open →
FY20232023-12-31$136M+0.6%Open →
FY20222022-12-31$135M+159.3%Open →
FY20212021-12-31$52.1M−14.7%Open →
FY20202020-12-31$61.0M+35.4%Open →
FY20192019-12-31$45.1M−26.1%Open →
FY20182018-12-31$61.0M+81.4%Open →
FY20172017-12-31$33.6M−16.8%Open →
FY20162016-12-31$40.4M−20.5%Open →
FY20152015-12-31$50.8M−16.5%Open →
FY20142014-12-31$60.9M−6.0%Open →
FY20132013-12-31$64.8M−27.0%Open →
FY20122012-12-31$88.8M+1.0%Open →
FY20112011-12-31$87.9M—Open →

Cash — Cash and cash equivalents is money available immediately at the balance-sheet date. It excludes short-term investments, which many large companies hold far more of.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth −0.3%

Cash at companies of similar size

Full ranking by cash →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Vanda Pharmaceuticals cash |url=https://companiesranked.com/en/company/vanda-pharmaceuticals/cash-on-hand |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Vanda Pharmaceuticals cash. CompaniesRanked. https://companiesranked.com/en/company/vanda-pharmaceuticals/cash-on-hand

BibTeX

@misc{companiesranked-en-company-vanda-pharmaceuticals-cash-on-hand-2026,
  author       = {{CompaniesRanked}},
  title        = {{Vanda Pharmaceuticals cash}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/vanda-pharmaceuticals/cash-on-hand}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-Q · 0001628280-26-053855 · August 6, 2026

{{cite web |title=Vanda Pharmaceuticals cash — 10-Q (0001628280-26-053855) |url=https://www.sec.gov/Archives/edgar/data/1347178/000162828026053855/vnda-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-06}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Vanda Pharmaceuticals overview